FDA Fast-Tracks Psychedelic Drug Approvals to Combat Mental Health Crisis FDA Fast-Tracks Psychedelic Drug Approvals to Combat Mental Health Crisis WASHINGTON — In a decisive move to expand the arsenal of psychiatric medicine, the U.S. Food and Drug Administration (FDA) is accelerating the review process for a new wave of psychedelic therapies aimed at treating … Read more
FDA Approves Merck’s Idvynso: A New Alternative for HIV Patients Switching from Biktarvy In a move that reshapes the competitive landscape of antiretroviral therapy, the U.S. Food and Drug Administration has granted a FDA nod for Merck’s HIV drug Idvynso. This approval provides a vital new lifeline for patients who have struggled with existing treatments. … Read more
FDA Grants Historic Approval to Filspari for Rare Kidney Disease FSGS WASHINGTON — In a watershed moment for nephrology, the U.S. Food and Drug Administration (FDA) has granted approval to Filspari, marking the first-ever approved pharmacological treatment for focal segmental glomerulosclerosis (FSGS). Developed by Travere Therapeutics, the medication represents a critical breakthrough for patients battling … Read more
FDA Commissioner Makary Marks One Year Amidst Agency Transformation WASHINGTON – Food and Drug Administration Commissioner Marty Makary addressed agency staff Wednesday, reflecting on the FDA’s accomplishments over the past year while acknowledging a difficult beginning to his leadership. The speech came on the anniversary of significant workforce reductions at the Department of Health and … Read more
Eli Lilly’s Foundayo Receives FDA Approval, Intensifying Competition in Weight Loss Medications In a significant development for individuals managing obesity and related health conditions, the Food and Drug Administration (FDA) has granted approval to Eli Lilly’s Foundayo (orforglipron), an oral glucagon-like peptide-1 (GLP-1) receptor agonist. This approval arrives approximately three months after Novo Nordisk introduced … Read more
<p>Every 3 seconds, someone in the world is diagnosed with dementia. That’s a staggering statistic, and one that highlights the urgent need for earlier, more accurate diagnostic tools. But what if those tools weren’t reliant solely on human interpretation? A wave of new applications leveraging artificial intelligence are poised to redefine healthcare, offering the promise … Read more
Key FDA Infectious Disease Regulator Announces Departure WASHINGTON – A significant shift is occurring within the Food and Drug Administration as Adam Sherwat, the director overseeing the review of infectious disease products, prepares to leave his post. The announcement, made via internal communication on Wednesday, signals a change in leadership at a critical juncture for … Read more
New FDA Drug for Rare Disease: A First-Time Approval
FDA Approves Leucovorin for Cerebral Folate Deficiency, Following Autism Research Discussion In a landmark decision, the Food and Drug Administration (FDA) has granted approval for the use of leucovorin in treating cerebral folate deficiency, a rare genetic disorder. This approval arrives several months after FDA Commissioner Dr. Marty Makary publicly highlighted the potential of this … Read more
The Looming Crisis in Autism Treatment: Beyond Leucovorin and Towards Personalized Precision Over 600 families in the United States are grappling with a sudden reversal of fortune, their hopes dashed as a potential treatment for autism – leucovorin – has been reclassified by the FDA. Initially touted as a breakthrough for a rare genetic disorder … Read more
Lady Gaga’s openness about her mental health struggles, including a psychotic break and treatment with lithium, has ignited a crucial conversation about mood stabilization and potential alternatives. While lithium carbonate remains a gold-standard treatment for bipolar disorder, emerging research and expert opinions are highlighting a potentially safer, more accessible option: lithium orotate. This isn’t simply … Read more